V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20222025 | 20180031 | 1.8 | null | Palliative (P) | 2020-04-17 | 2020-05-09 | null | 02 | null | ECX | 100851418 |
| 20222368 | 20180033 | 1.62 | null | Palliative (P) | 2016-11-02 | 2016-11-10 | Carboplatin + Etoposide IV 3 day | 02 | N | CARBOPLATIN + ETOPOSIDE | 100319905 |
| 20222799 | 20180035 | null | 56.2 | null | 2020-02-11 | 2020-02-11 | ECX | 02 | null | ECX | 100053931 |
| 20222811 | 20180036 | null | null | Palliative (P) | 2016-12-24 | 2017-03-06 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101581646 |
| 20222830 | 20180037 | 1.55 | 85.7 | null | null | 2018-09-20 | ECX | 02 | null | ECX | 101294353 |
| 20222951 | 20180038 | 1.64 | 69.6 | Palliative (P) | 2020-02-29 | 2020-02-29 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101348673 |
| 20223430 | 20180041 | 1.69 | null | null | 2018-02-18 | 2018-02-20 | NIVOLUMAB | null | null | NIVOLUMAB | 101818952 |
| 20223463 | 20180042 | 1.71 | 74.6 | null | 2017-06-28 | 2017-08-15 | null | 02 | N | CISPLATIN + FLUOROURACIL | 100218749 |
| 20223545 | 20180043 | 1.71 | 70.1 | Palliative (P) | 2017-11-06 | 2017-11-18 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101021219 |
| 20223741 | 20180044 | 1.64 | 74.8 | Palliative (P) | 2016-11-15 | 2016-12-10 | null | N | null | CISPLATIN + FLUOROURACIL | 100284227 |
| 20223899 | 20180046 | 1.65 | 60.9 | null | 2019-06-30 | 2019-07-20 | null | null | N | PANITUMUMAB | 101350599 |
| 20223978 | 20180047 | 1.54 | 115 | null | 2019-12-29 | 2020-01-19 | Panitumumab | 02 | null | PANITUMUMAB | 100936578 |
| 20224015 | 20180048 | 1.62 | 52.8 | Palliative (P) | 2021-08-12 | 2021-08-28 | Panitumumab | null | N | PANITUMUMAB | 100839151 |
| 20224037 | 20180049 | 1.7 | null | null | 2018-08-02 | 2018-08-04 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101596662 |
| 20224087 | 20180050 | null | 77.8 | null | 2020-12-27 | 2021-01-02 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100971602 |
| 20224360 | 20180051 | 1.58 | 103.3 | null | 2017-07-28 | 2017-08-01 | Panitumumab | 02 | null | PANITUMUMAB | 101589696 |
| 20224381 | 20180052 | 1.65 | 121.8 | Curative (C) | 2016-12-03 | 2016-12-10 | null | 02 | N | NIVOLUMAB | 100311757 |
| 20224386 | 20180053 | 1.81 | 85.2 | Adjuvant (A) | null | 2019-06-30 | null | N | Y | ECX | 100600064 |
| 20224549 | 20180054 | 1.76 | 65.15 | Palliative (P) | null | 2016-09-16 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100963001 |
| 20224653 | 20180055 | 1.75 | 51.8 | Curative (C) | 2019-01-31 | 2019-07-06 | Panitumumab | 02 | N | PANITUMUMAB | 100633752 |
| 20224756 | 20180056 | 1.57 | null | Palliative (P) | 2019-06-18 | 2019-06-18 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101464262 |
| 20224768 | 20180057 | 1.58 | 74.2 | Curative (C) | 2017-05-04 | 2017-06-11 | ECX | 2 | N | ECX | 100177448 |
| 20224857 | 20180058 | null | 59 | Palliative (P) | 2018-08-24 | 2018-09-14 | null | 02 | N | ECX | 100499662 |
| 20224935 | 20180059 | 1.69 | 53.7 | Palliative (P) | 2016-08-20 | 2016-09-06 | CAPECITABINE + RT | 2 | N | CAPECITABINE + RT | 100659852 |
| 20224959 | 20180060 | 1.56 | 82.8 | Palliative (P) | 2018-09-03 | 2018-09-24 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101029100 |
| 20225173 | 20180061 | 1.7 | 67.1 | Palliative (P) | 2019-10-09 | 2019-10-10 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 101728732 |
| 20225562 | 20180062 | 1.85 | 91 | Neo-adjuvant (N) | 2017-10-26 | 2017-10-29 | Oxaliplatin + Raltitrexed | 02 | Y | OXALIPLATIN + RALTITREXED | 100346891 |
| 20001010 | 20180063 | 1.64 | 85.9 | null | 2019-07-08 | 2019-08-25 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101744577 |
| 20001746 | 20180064 | 1.71 | 95.8 | Palliative (P) | 2019-08-10 | 2019-08-10 | Trial Unspecified | 02 | N | TRIAL | 100062213 |
| 20002481 | 20180065 | 1.45 | 101.2 | Palliative (P) | 2020-08-01 | 2021-06-10 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101721790 |
| 20004034 | 20180066 | 1.58 | 102.7 | Neo-adjuvant (N) | 2021-05-27 | 2021-06-16 | Cetuximab + FOLFIRI cycle1 | N | N | CETUXIMAB + IRINOTECAN + MDG | 100599996 |
| 20004464 | 20180067 | 1.78 | 73 | null | 2021-11-26 | 2021-11-26 | Sorafenib | 02 | null | SORAFENIB | 101744780 |
| 20007469 | 20180068 | 1.57 | 94 | Adjuvant (A) | 2021-06-13 | 2021-09-03 | EOX | 02 | N | CAPECITABINE + RT | 100543302 |
| 20007859 | 20180069 | 1.74 | 82.4 | Palliative (P) | 2018-02-10 | 2018-05-30 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101240520 |
| 20007934 | 20180070 | 1.72 | 75.2 | Palliative (P) | 2017-10-11 | 2018-01-02 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100324232 |
| 20010911 | 20180071 | 1.75 | 70 | Palliative (P) | 2018-12-02 | 2019-10-25 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | Y | Y | CETUXIMAB + IRINOTECAN + MDG | 101340964 |
| 20011580 | 20180072 | 1.56 | 89 | Curative (C) | 2017-08-06 | 2017-08-12 | EOX | 1 | N | CETUXIMAB + IRINOTECAN + MDG | 100325417 |
| 20013213 | 20180073 | null | null | null | 2020-05-03 | 2020-07-13 | Sorafenib | 02 | null | SORAFENIB | 101845907 |
| 20013573 | 20180075 | 1.66 | 74.4 | null | 2021-01-31 | 2021-04-14 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100579573 |
| 20018460 | 20180078 | 1.58 | 74.9 | Palliative (P) | 2019-11-08 | 2020-04-28 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100738134 |
| 20018951 | 20180080 | 1.76 | null | Palliative (P) | 2018-07-28 | 2019-08-09 | EOX | 02 | N | SORAFENIB | 101044645 |
| 20022145 | 20180081 | 1.55 | 56 | null | 2020-05-29 | 2020-06-13 | EOX | 1 | null | TRIAL | 101355962 |
| 20025132 | 20180083 | 1.72 | 81.7 | Palliative (P) | 2021-12-28 | 2022-01-22 | EOX | 02 | N | EOX | 101203305 |
| 20026284 | 20180084 | 1.73 | 54 | null | null | 2019-01-04 | LENVATINIB | 02 | null | LENVATINIB | 100395560 |
| 20026492 | 20180085 | 0 | 0 | Palliative (P) | 2021-09-02 | 2021-09-30 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101571141 |
| 20027248 | 20180086 | 0 | null | null | 2022-01-10 | 2022-04-17 | null | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101162594 |
| 20027278 | 20180087 | 0 | null | Palliative (P) | 2016-06-12 | 2016-06-22 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100900697 |
| 20027529 | 20180088 | 0 | null | null | 2019-07-29 | 2019-08-04 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | HCX | 100123364 |
| 20028008 | 20180089 | 0 | 70.7 | null | 2019-12-27 | 2020-07-18 | null | 02 | null | FLUOROURACIL + MITOMYCIN | 101441680 |
| 20028872 | 20180090 | 0 | 63.4 | Palliative (P) | 2020-06-21 | 2021-05-16 | null | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100200258 |